Gene expression profiles of ABC transporters and cytochrome P450 3A in Caco-2 and human colorectal cancer cell lines

被引:30
作者
Nakamura, T
Sakaeda, T
Ohmoto, N
Moriya, Y
Komoto, C
Shirakawa, T
Gotoh, A
Matsuo, M
Okumura, K [1 ]
机构
[1] Kobe Univ, Sch Med, Dept Hosp Pharm, Chuo Ku, Kobe, Hyogo 6500017, Japan
[2] Kobe Univ, Sch Med, Dept Urol, Chuo Ku, Kobe, Hyogo 6500017, Japan
[3] Kobe Univ, Sch Med, Dept Clin Genet, Chuo Ku, Kobe, Hyogo 6500017, Japan
[4] Kobe Univ, Sch Med, Int Ctr Med Res, Chuo Ku, Kobe, Hyogo 6500017, Japan
关键词
MDR1; multidrug resistance-associated protein (MRP); villin; in vitro screening model;
D O I
10.1023/A:1022251910820
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. The mRNA levels of MDR1 (P-glycoprotein), multidrug resistance-associated proteins (MRP1, MRP2), cytochrome P450 3A (CYP3A) and villin in human colorectal cell lines (HCT-15, LoVo, DLD-1, HCT-116 and SW620) were quantitatively compared with those in Caco-2 cells. Methods. The mRNA levels were determined by real time quantitative polymerase chain reaction and expressed as the relative concentrations of MDR1 mRNA to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA. Results. MDR1 mRNA was expressed in HCT-15 LoVo and DLD-1 cells at similar or lower level to Caco-2. The expression of MRP1 mRNA in the cell lines tested was comparable with Caco-2. MRP2 mRNA was detected only in HCT-116 and SW620 at significantly lower level than Caco-2. CYP3A mRNA was detected in HCT-15, LoVo, DLD-1 and SW620 at similar level to Caco-2. Conclusions. HCT-15 LoVo and DLD-1 cells express proteins important for regulating the intestinal absorption of drugs, i.e., MDR1, MRP1 and CYP3A, whereas HCT-116 and SW620 cells were not acceptable for evaluation of absorption properties of drug candidates.
引用
收藏
页码:324 / 327
页数:4
相关论文
共 15 条
[1]   Intestinal drug absorption and metabolism in cell cultures: Caco-2 and beyond [J].
Artursson, P ;
Borchardt, RT .
PHARMACEUTICAL RESEARCH, 1997, 14 (12) :1655-1658
[2]   Caco-2 monolayers in experimental and theoretical predictions of drug transport (Reprinted from Advanced Drug Delivery Reviews, vol 22, pg 67-84, 1996) [J].
Artursson, P ;
Palm, K ;
Luthman, K .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 46 (1-3) :27-43
[3]   The drug efflux-metabolism alliance: biochemical aspects [J].
Benet, LZ ;
Cummins, CL .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 50 :S3-S11
[4]  
Boulenc X, 1997, STP PHARMA SCI, V7, P259
[5]   Characterizing the expression of CYP3A4 and efflux transporters (P-gp, MRP1, and MRP2) in CYP3A4-transfected Caco-2 cells after induction with sodium butyrate and the phorbol ester 12-O-tetradecanoylphorbol-13-acetate [J].
Cummins, CL ;
Mangravite, LM ;
Benet, LZ .
PHARMACEUTICAL RESEARCH, 2001, 18 (08) :1102-1109
[6]   CYP3A4, CYP3A5, and MDR1 in human small and large intestinal cell lines suitable for drug transport studies [J].
Engman, HA ;
Lennernäs, H ;
Taipalensuu, J ;
Otter, C ;
Leidvik, B ;
Artursson, P .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 90 (11) :1736-1751
[7]   Carrier-mediated transport and efflux mechanisms in Caco-2 cells [J].
Hidalgo, IJ ;
Li, JB .
ADVANCED DRUG DELIVERY REVIEWS, 1996, 22 (1-2) :53-66
[8]  
Hirohashi T, 2000, J PHARMACOL EXP THER, V292, P265
[9]   Multiple physiological functions for multidrug transporter P-glycoprotein? [J].
Johnstone, RW ;
Ruefli, AA ;
Smyth, MJ .
TRENDS IN BIOCHEMICAL SCIENCES, 2000, 25 (01) :1-6
[10]   Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine [J].
Lown, KS ;
Mayo, RR ;
Leichtman, AB ;
Hsiao, HL ;
Turgeon, DK ;
SchmiedlinRen, P ;
Brown, MB ;
Guo, WS ;
Rossi, SJ ;
Benet, LZ ;
Watkins, PB .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 62 (03) :248-260